NASDAQ:MLYS | Profit Breakdown | Mineralys Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$246.04M-$241.07M
2026-03-31-$45.34M-$39.34M
2025-12-31-$38.28M-$32.23M
2025-09-30-$41.13M-$36.93M
2025-06-30-$46.75M-$43.27M
2025-03-31-$44.45M-$42.21M
2024-12-31-$51.77M-$48.95M
2024-09-30-$60.11M-$56.34M
2024-06-30-$45.17M-$41.01M
2024-03-31-$35.36M-$31.51M
2023-12-31-$27.71M-$24.39M
2023-09-30-$26.27M-$22.76M
2023-06-30-$15.74M-$12.14M
2023-03-31-$14.94M-$12.61M
2022-12-31-$10.01M-$9.07M
2022-09-30-$7.42M-$6.68M
2022-06-30-$6.48M-$6.48M
2022-03-31-$7.57M-$7.57M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$170.6M-$154.65M
2024-12-31-$192.4M-$177.81M
2023-12-31-$84.66M-$71.9M
2022-12-31-$31.48M-$29.8M